OCLI Research Department (01-007) — Oceanside, New York

OCLI Research Department (01-007) is a clinical research site located in Oceanside, New York, United States 11572.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

OCLI Research Department (01-007) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Geographic Atrophy.

Sponsors: Apellis Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oceanside

Browse all research sites in New York · View every site in Oceanside

• South Nassau Communities Hospital
• Ophthalmic Consultants of Long Island
• Mount Sinai South Nassau
• Ophthalmic Cons of Long Island
• South Nassau Communities
• Ocli Vision
• Ophthalmic Consultants Long Island /ID# 240211
• South Nassau Dermatology /ID# 17065
• TrialSpark, Inc (Russell Cohen)
• Oceanside, NY
• South Nassau Dermatology, P.C.

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OCLI Research Department (01-007)?

OCLI Research Department (01-007) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OCLI Research Department (01-007) conducted?

OCLI Research Department (01-007) has 1 clinical trials on record, with 1 currently active. Their work covers Geographic Atrophy.

Is OCLI Research Department (01-007) accredited by Crixeo Clinical Trials?

OCLI Research Department (01-007) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OCLI Research Department (01-007)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.